PULMATRIX, INC. (PULM) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
21/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinPULM / S&P 31.78% / 15.20% |
LosePULM / S&P PULM unavailable / 15.00% |
LosePULM / S&P -49.54% / 50.40% |
| 2026-Q10/3 |
LosePULM / S&P -42.15% / -4.33% |
LosePULM / S&P PULM unavailable / 11.30% |
LosePULM / S&P -63.28% / 27.70% |
| 2025-Q40/3 |
LosePULM / S&P -54.12% / 2.65% |
LosePULM / S&P PULM unavailable / 9.00% |
LosePULM / S&P -46.18% / 13.40% |
| 2025-Q30/3 |
LosePULM / S&P -29.57% / 8.12% |
LosePULM / S&P PULM unavailable / 4.61% |
LosePULM / S&P -35.23% / 13.45% |
| 2025-Q20/3 |
LosePULM / S&P 3.60% / 10.94% |
LosePULM / S&P PULM unavailable / 4.83% |
LosePULM / S&P -26.35% / 10.63% |
| 2025-Q11/3 |
LosePULM / S&P -4.58% / -4.27% |
LosePULM / S&P PULM unavailable / 4.98% |
WinPULM / S&P 39.00% / 10.57% |
| 2024-Q42/3 |
WinPULM / S&P 226.17% / 2.41% |
WinPULM / S&P 6.96% / 5.25% |
LosePULM / S&P -32.12% / 6.15% |
| 2024-Q32/3 |
WinPULM / S&P 10.88% / 5.89% |
WinPULM / S&P 47.05% / 5.89% |
LosePULM / S&P -40.41% / 6.11% |
| 2024-Q22/3 |
WinPULM / S&P 10.29% / 4.28% |
WinPULM / S&P 64.55% / 5.38% |
LosePULM / S&P -38.97% / 5.12% |
| 2024-Q11/3 |
LosePULM / S&P -5.91% / 10.56% |
WinPULM / S&P 82.28% / 5.71% |
LosePULM / S&P -53.38% / 5.59% |
| 2023-Q41/3 |
LosePULM / S&P -8.37% / 11.69% |
WinPULM / S&P 20.21% / 6.81% |
LosePULM / S&P PULM unavailable / 7.78% |
| 2023-Q31/3 |
LosePULM / S&P -24.25% / -3.27% |
WinPULM / S&P 41.19% / 7.52% |
LosePULM / S&P PULM unavailable / -5.03% |
| 2023-Q21/3 |
LosePULM / S&P -8.22% / 8.74% |
WinPULM / S&P 72.39% / 9.50% |
LosePULM / S&P PULM unavailable / -8.57% |
| 2023-Q11/3 |
LosePULM / S&P -24.74% / 7.50% |
WinPULM / S&P 29.78% / 10.77% |
LosePULM / S&P PULM unavailable / -15.69% |
| 2022-Q42/3 |
WinPULM / S&P 8.68% / 7.56% |
WinPULM / S&P 17.45% / 11.88% |
LosePULM / S&P PULM unavailable / -17.99% |
| 2022-Q30/3 |
LosePULM / S&P -22.22% / -4.88% |
LosePULM / S&P -28.21% / 13.47% |
LosePULM / S&P PULM unavailable / -1.41% |
| 2022-Q20/3 |
LosePULM / S&P -32.80% / -16.10% |
LosePULM / S&P -59.90% / 13.71% |
LosePULM / S&P PULM unavailable / 11.04% |
| 2022-Q10/3 |
LosePULM / S&P -22.03% / -4.60% |
LosePULM / S&P -56.14% / 15.97% |
LosePULM / S&P PULM unavailable / 42.23% |
| 2021-Q40/3 |
LosePULM / S&P -45.25% / 11.03% |
LosePULM / S&P -59.09% / 15.00% |
LosePULM / S&P PULM unavailable / 96.40% |
| 2021-Q30/3 |
LosePULM / S&P -23.08% / 0.58% |
LosePULM / S&P -45.51% / 10.77% |
LosePULM / S&P PULM unavailable / 69.42% |
| 2021-Q21/3 |
LosePULM / S&P -21.80% / 8.55% |
WinPULM / S&P 7.09% / 6.58% |
LosePULM / S&P PULM unavailable / 51.81% |
| 2021-Q12/3 |
WinPULM / S&P 11.76% / 6.17% |
WinPULM / S&P 5.53% / -1.06% |
LosePULM / S&P PULM unavailable / 7.39% |
| 2020-Q40/3 |
LosePULM / S&P 0.00% / 12.15% |
LosePULM / S&P PULM unavailable / -3.72% |
LosePULM / S&P PULM unavailable / -33.42% |
| 2020-Q30/3 |
LosePULM / S&P -30.81% / 8.93% |
LosePULM / S&P PULM unavailable / -2.04% |
LosePULM / S&P PULM unavailable / -27.10% |
| 2020-Q21/3 |
WinPULM / S&P 70.30% / 20.54% |
LosePULM / S&P PULM unavailable / -0.46% |
LosePULM / S&P PULM unavailable / -27.11% |
| 2020-Q11/3 |
WinPULM / S&P 17.44% / -19.60% |
LosePULM / S&P PULM unavailable / 3.47% |
LosePULM / S&P PULM unavailable / -14.75% |
| 2019-Q40/3 |
LosePULM / S&P 5.13% / 9.07% |
LosePULM / S&P PULM unavailable / 5.36% |
LosePULM / S&P PULM unavailable / 2.99% |
| 2019-Q30/3 |
LosePULM / S&P -11.28% / 1.70% |
LosePULM / S&P PULM unavailable / 5.02% |
LosePULM / S&P PULM unavailable / 0.21% |
| 2019-Q20/3 |
LosePULM / S&P -27.40% / 4.30% |
LosePULM / S&P PULM unavailable / 6.64% |
LosePULM / S&P PULM unavailable / 8.65% |
| 2019-Q10/3 |
LosePULM / S&P -47.08% / 13.65% |
LosePULM / S&P PULM unavailable / 8.12% |
LosePULM / S&P PULM unavailable / 14.29% |
| 2018-Q40/3 |
LosePULM / S&P -35.14% / -13.52% |
LosePULM / S&P PULM unavailable / 9.05% |
LosePULM / S&P PULM unavailable / 18.23% |
| 2018-Q30/3 |
LosePULM / S&P -17.78% / 7.71% |
LosePULM / S&P PULM unavailable / 10.21% |
LosePULM / S&P PULM unavailable / 19.06% |
| 2018-Q20/3 |
LosePULM / S&P -11.59% / 3.43% |
LosePULM / S&P PULM unavailable / 9.03% |
LosePULM / S&P PULM unavailable / 14.46% |
| 2018-Q10/3 |
LosePULM / S&P -63.90% / -0.76% |
LosePULM / S&P PULM unavailable / 7.68% |
LosePULM / S&P PULM unavailable / 12.46% |
| 2017-Q40/3 |
LosePULM / S&P -31.22% / 6.64% |
LosePULM / S&P PULM unavailable / 7.03% |
LosePULM / S&P PULM unavailable / 13.82% |
| 2017-Q30/3 |
LosePULM / S&P -13.87% / 4.48% |
LosePULM / S&P PULM unavailable / 5.68% |
LosePULM / S&P PULM unavailable / 17.57% |
| 2017-Q20/3 |
LosePULM / S&P -31.81% / 3.09% |
LosePULM / S&P PULM unavailable / 4.83% |
LosePULM / S&P PULM unavailable / 17.74% |
| 2017-Q11/3 |
WinPULM / S&P 491.53% / 6.07% |
LosePULM / S&P PULM unavailable / 3.67% |
LosePULM / S&P PULM unavailable / 13.32% |
| 2016-Q40/3 |
LosePULM / S&P -64.24% / 3.82% |
LosePULM / S&P -30.56% / 2.09% |
LosePULM / S&P PULM unavailable / 7.05% |
| 2016-Q30/3 |
LosePULM / S&P -15.82% / 3.85% |
LosePULM / S&P -20.00% / 0.20% |
LosePULM / S&P PULM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PULM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -69.17% | 20.78% |
| Annualized return | -69.17% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PULM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.80% | 83.14% |
| Annualized return | -37.95% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PULM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.52% | 319.30% |
| Annualized return | -41.36% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |